161798-01-2 Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate 99%

Since inception in 1993 Everest Organics Limited has been in the forefront of API manufacture. We employ a strategic mix of seasoned chemists and analysts with years of experience and practical know-how, alongside a younger generation of similarly educated professionals.

In 1995, the company became a public listed company and was listed on the BSE.   Portfolio of 30 + API’s across various therapeutic categories manufactured at our state of the art USFDA approved facility.  Portfolio of 32 + Key starting materials and Intermediates customized to cater the demands of our clients globally.

The Contract Research and Manufacturing Services (CRAMs) at Everest Organics Limited provide services to pharma companies looking to outsource for increased efficiency and affordable costs for API’s.  We provide Co-development and Custom Synthesis for our customers, thereby making investments more feasible for economical manufacturing with superior research.